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Abstract 
Background: 
In this field study of WHO‘s revised classification of mental disorders for primary 
care settings, we tested the usefulness of two five-item screening scales for anxiety 
and depression to be administered in primary care settings.  
Methods: 
The study was conducted in primary care settings in four large middle-income 
countries. Primary care physicians (PCPs) referred individuals who they suspected 
might be psychologically distressed to the study. Screening scales as well as a 
structured diagnostic interview, the Clinical Interview Schedule, Revised (CIS-R), 
adapted for proposed decision rules in ICD-11 PHC, were administered to 1,488 
participants. 
Results 
A score of 3 or more on one or both screening scale predicted 89.6% of above-
threshold mood or anxiety disorder diagnoses on the CIS-R. Anxious depression was 
by far the most common CIS-R diagnosis. However, there was an exact diagnostic 
match between the screening scales and the CIS-R in only 62.9% of those with high 
scores.  
Limitations 
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This study was confined to those in whom the PCP suspected psychological distress, 
so does not provide information about the prevalence of various mental disorders in 
primary care settings.  
Conclusions 
The two five-item screening scales for anxiety and depression provide a practical way 
for PCPs to evaluate the likelihood of mood and anxiety disorders without paper and 
pencil measures that are not feasible in many settings. These scales may provide 
substantially improved case detection as compared to current primary care practice, 
and offer a realistic alternative to complex diagnostic algorithms used by specialist 
mental health professionals.  
Key words: Anxiety; Depression; Primary Care; Screening; ICD-11 
 
 
The World Health Organization (WHO) is preparing a revised version of the 
classification of mental disorders for primary health care (ICD-10 PHC; WHO, 1996)
 
as part of the 11
th
 revision of the International Classification of Diseases. Proposals 
for a new primary care classification have been developed by a working group 
comprising equal numbers of primary care physicians (PCPs) with a special interest in 
mental disorders and mental health professionals engaged in teaching mental health 
skills to PCPs.  A separate classification of mental disorders for primary care is 
needed because the parent classification provides a poor fit to common mental 
disorders as presented in primary care settings (Gask, Klinkman, Fortes, & Dowrick, 
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2008), which are often in an earlier and less severe form than those seen by mental 
health professionals (Goldberg, 2011).  Existing specialist mental disorders 
classifications (American Psychiatric Association, 2013; WHO, 1992) tend to ignore 
anxiety symptoms unless they have lasted for several months, while depressive 
episodes can be diagnosed after a period of two weeks. Yet many depressed people 
are also currently anxious (Goldberg, Prisciandaro, and Williams, 2012), and 
consistent differences between depression with and without anxious symptoms have 
been found in studies that have examined the specific contribution of anxiety to 
clinical status (Fava et al. 2008; Goldberg & Fawcett, 2012; Goldberg, Wittchen, 
Zimmerman, Pfister, & Beesdo-Baum, 2014). It is important for PCPs to take account 
of the patient‘s clinical state at the time when treatment is sought, and to be aware of 
differences in ease of treatment, clinical outcome, and suicidal risk. 
As proposed, the revised primary care classification for ICD-11 Mental and 
Behavioural Disorders (ICD-11 PHC) considers anxious depression to be an 
important form of depressive episode in general medical practice (Goldberg  2014; 
Silverstone & von Studnitz, 2003), diagnosed when the patient satisfies requirements 
for both current anxiety and depression, using the same 2-week duration requirement 
for both. Goldberg and Fawcett (2012) argued that when depression is accompanied 
by current anxiety, the risk of suicide is greater and the course of illness is less 
responsive to treatment. Such patients often also present with somatic complaints. In 
the proposed ICD-11 PHC, depressive episode also requires a duration of 2 weeks, 
and should be diagnosed when there are no or few symptoms of anxiety; conversely, 
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current anxiety should be diagnosed when anxiety symptoms have persisted for 
more than 2 weeks but there are few or no symptoms of depression.  
Goldberg and colleagues (2012) used data from a previous WHO study of 
mental disorders in general medical and primary care settings in 14 countries (Üstün 
& Sartorius, 1995) to show that the correlation between anxious and depressive 
symptoms was +0.88 and that anxious depression is much more common in primary 
care settings than ―co-morbid generalized anxiety and depression‖, where the 
individual meets the diagnostic requirements of both a depressive episode and 
generalized anxiety disorder using a duration requirement of 6 months for anxiety 
symptoms. Kessler and his colleagues have confirmed that briefer durations of 
anxiety are predictive of subsequent psychopathology and have just as much 
associated disability at 6-month follow-up as longer durations (Kessler et al., 2005; 
Ruscio et al., 2007). In addition, subclinical mixed depression and anxiety, in which 
significant symptoms of both anxiety and depression are present but neither set of 
symptoms satisfies diagnostic requirements for depression or an anxiety disorder, has 
been shown to be a major cause of psychiatric morbidity in primary care settings. In 
the UK, it has been shown to account for 20.3% of all time off work, as compared to 
depression, which only accounts for 8.2% (Das-Munshi et al., 2008).  
Definitions based of the above descriptions were submitted to a range of 
experts on mental disorders in primary care settings around the world, and focus 
groups were conducted in eight countries (Lam et al., 2013) in order to obtain the 
views of working PCPs and nurses on the proposed changes to the ICD-10 PHC 
classification. The proposal for a new category of anxious depression was universally 
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welcomed by the primary care professionals participating in the focus groups.  
 Depressive and anxiety disorders have been repeatedly established as very 
common in primary care settings in studies conducted in a range of countries around 
the world (see, for example, King et al., 2008; Kroenke, Spitzer, Williams, Monahan, 
& Löwe, 2007; Pothen, Kuravilla, Philip, Joseph, & Jacob, 2003; Spiers et al., 2016; 
Üstün & Sartorius, 1995). In spite of the prevalence and importance of these 
conditions in primary care and their substantial contribution to disability (Whiteford 
et al., 2013), rates of identification and treatment remain very low, with less than half 
of depressive episodes correctly identified even in high-resource primary care settings 
(Mitchell, Vaze, & Rao, 2009). PCPs are under ever-increasing time pressure; there 
are competing demands for the clinician‘s attention during encounters that typically 
last only a few minutes, and there is insufficient time to address each demand 
(Klinkman, 1997). Even mental health specialists have difficulty remembering the 
complex diagnostic algorithms for mood disorder in current diagnostic systems 
(Zimmerman, Chelminski, McGlinchey, & Young, 2006). Therefore, PCPs are in 
great need of feasible and accurate screening procedures for depression and anxiety. 
However, existing paper and pencil screening tests are not available or appropriate in 
many global settings for reasons of language or literacy. These difficulties are likely 
to be even more pronounced in low- and middle-income countries, where more than 
80% of the world‘s population lives. This study tested very brief assessments of 
depression and anxiety consisting of only a minimal number of additional questions 
designed to be asked directly by the PCP, thus minimizing the additional time 
required in the patient encounter and obviating the need for paper and pencil tests and 
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instrument scoring. In addition, these screening questions were tied directly to the 
proposed diagnostic guidelines for depression and anxiety in the ICD-11 PHC.  
 Brief candidate screening scales for depression and anxiety had been derived 
from an earlier WHO study of psychological disorders in primary care carried out in 
14 countries (Üstün & Sartorius, 1995). In this study, a stratified random sample of 
5,438 primary care patients had been assessed using DSM-III-R criteria for common 
mental disorders, but with the duration requirement for a diagnosis of anxiety disorder 
reduced to one month. From these symptom data, five-item screening scales for 
depression and anxiety were derived using item response theory (Goldberg et al., 
2012). The sensitivity of the five-item depression scale for major depression was 
found to be 90% and specificity 88.5%, while for generalised anxiety disorder 
sensitivity of the five-item anxiety scale was found to be 79.8% and specificity 72.5% 
(Goldberg et al. 2012).  
The aim of the present study was to evaluate the ability of these two brief 
screening scales to identify cases of depression and anxiety in primary care settings in 
four large middle-income countries (Brazil, China, Mexico, and Pakistan) in order to 
consider their potential usefulness to global PCPs in arriving at a preliminary 
assessment. To minimize necessary PCP time for administration, each scale was 
structured so as to consist of two screening questions and an additional set of three 
questions to be asked if either of the screening items was positive. A related aim was 
to determine the best threshold scores on these scales for detecting ICD-11 cases of 
depression and anxiety. The results of the screening scales were compared with a 
structured psychiatric interview designed for use in the general population, the revised 
Screening for anxiety, depression, and anxious depression in primary care 
 
 
 
8 
Clinical Interview Schedule (CIS-R: Lewis, Pelosi, Araya, & Dunn, 1992), adapted 
according to the proposals for ICD-11 PHC to use a duration requirement of only 2 
weeks for current anxiety, to yield a diagnosis of anxious depression when patients 
met the requirements of both current depressive episode and current anxiety, and to 
yield a diagnosis of subclinical mixed depression and anxiety to patients who had 
significant symptoms of both depression and anxiety but did not meet the full 
diagnostic requirements of either disorder separately.  
Methods 
The present field study was carried out in primary care settings in Brazil (São 
Paulo and Rio de Janeiro), the People‘s Republic of China (Hong Kong), Mexico 
(Zapopan), and Pakistan (Rawalpindi). These are large lower and upper middle-
income countries in diverse regions of the world, representing a substantial portion of 
the global population and encompassing multiple languages and wide cultural 
variations. Centers were selected based on local investigator interest and ability to 
identify institutional resources in order to complete the study.  
The point of the present study was not to examine the prevalence of 
depressive and anxiety disorders in primary care settings, which has been the focus of 
other studies. Rather, the study used a cross-sectional descriptive design in a 
population of patients who were suspected by their PCPs of possibly being 
psychologically distressed. This procedure was used in order to create an enriched 
sample in whom a psychological disorder was more likely in order to be able to 
examine the relationship between two brief screening instruments and diagnoses 
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produced by the detailed psychiatric interview, as well as to replicate the conditions 
under which PCPs would be most likely to consider screening for such conditions. 
PCPs were asked to use a relatively low index of suspicion for inclusion in the study 
in order to include a sufficient proportion of non-cases in order to be able to examine 
the performance of the scales in differentiating cases from non-cases. The study was 
administered in the local language of each participating country, with back translation 
and comparison by the researchers with the original English language version. The 
protocol for the study (available from the Psychiatry Research Trust‘s website, 
http://www.psychiatryresearchtrust.co.uk/protocols/worldhealth.pdf) was approved by 
both the WHO Research Ethics Review Committee and the appropriate local 
Institutional Review Board at each participating center. 
At each center, the collaborating Local Investigator (LI) assembled a group of 
local PCPs who agreed to participate.  At a preliminary meeting with PCPs who were 
potentially interested in participating in the study, the LI reviewed the study 
procedure and, using a set of slides provided by WHO, reminded PCPs of aspects of 
patients‘ behavior that might alert them to the possible presence of psychological 
distress.  
Participants  
Participants were patients being seen for primary care visits as a part of usual 
care in one of the participating centers, who were at least 18 years or age and whose 
PCP suspected might be psychologically distressed.  Participating PCPs asked 
patients they considered to meet these criteria if they were interested in participating 
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in the study, which the PCP explained would involve undergoing a detailed 
interview administered by a research assistant.  
Procedure 
For patients who agreed to participate, the PCP completed a Patient Encounter 
Form, which included the two five-item screening scales for depression and anxiety 
shown below. PCPs were asked to administer the two preliminary screening questions 
for each scale, and only if they obtained a positive answer to either screening question 
to ask the remaining three questions. As noted above, the purpose of the two 
screening questions was to save time, given that PCPs often have only a few minutes 
for each patient.  On the Patient Encounter Form, PCPs also rated their view of the 
level of disability and distress associated with the mood and anxiety symptoms, 
whether a diagnosable disorder according to the new proposed guidelines was present, 
and the severity of the disorder. Very general but non-identifying demographic 
information (gender and age group) was recorded for patients who declined to 
participate in the study, as well as their reason for refusal. 
Brief screening scales for depression and anxiety 
Five-item depression scale: 
Screening items: 
D1 Have you been feeling depressed every day for the past 2 weeks? 
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D2 During the past two weeks, have you experienced less interest or 
pleasure from activities?  
Additional items (to be asked if positive response to either screening item): 
D3 During the past two weeks, have you experienced poor concentration? 
D4 During the past two weeks, have you experienced feelings of 
worthlessness? 
D5 During the past two weeks, have you felt you wanted to die or had 
thoughts of death? 
Five-item anxiety scale: 
Screening items: 
A1 Have you felt nervous or anxious during the past 2 weeks? 
A2 During the past 2 weeks, have you found that you are not able to 
control your worrying? 
Additional items (to be asked if positive response to either screening item): 
A3 During the past 2 weeks, have you had trouble relaxing? 
A4 During the past 2 weeks, have you felt so restless it was hard to keep 
still? 
Screening for anxiety, depression, and anxious depression in primary care 
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A5 During the past 2 weeks, have you felt afraid that something awful 
might happen? 
 Consenting patients were interviewed by a research assistant who was not 
aware of the PCP‘s evaluation beyond the suspicion of psychological distress, using a 
computerized version of the CIS-R. Patients were interviewed during the same visit if 
possible or during a scheduled return visit. The diagnostic interview had been adapted 
to make proposed ICD-11 diagnoses using the diagnostic requirements described 
earlier in this article. These adaptations consisted of using a duration requirement of 
only 2 weeks for current anxiety, assigning a diagnosis of anxious depression to 
patients who met the requirements of both current depressive episode and current 
anxiety, and assigning a diagnosis of subclinical mixed depression and anxiety to 
patients who had significant symptoms of both depression and anxiety but did not 
meet the full diagnostic requirements of either depression or current anxiety.  
Data analysis 
The primary measures used in the study were the two five-item screening 
scales for depression and anxiety shown above, and mood and anxiety disorder 
diagnoses produced by the CIS-R, using diagnostic algorithms consistent with the 
proposed ICD-11 PHC, as described above. The screening scales were scored as the 
number of positive items for depression, hereafter referred to as the Dep5 score, and 
the number of positive items for anxiety, referred to as the Anx5 score. Prediction of 
CIS-R diagnoses using the screening scales was assessed based on percentage of true 
cases with high scores and percentage of non-cases with low scores, and positive 
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predictive values (PPVs) and negative predictive values (NPVs) derived from ROC 
curves. PPVs and NPVs were calculated using the formula for general use provided 
Altman and Bland (1994) adapted by using country-specific values for the percentage 
of cases and non-cases correctly identified and the overall prevalence in the four 
countries. Optimized cutoff scores were selected using the Youden index (Youden, 
1950; see López-Ratón, Rodríguez-Álvarez, Cadarso-Suárez, & Gude-Sampedro, 
2014).  
The descriptive analyses for this study consisted of frequencies and 
proportions for socio-demographic and clinical characteristics by countries or by 
diagnostic groups. Between-group differences in frequencies (proportions) were 
tested using Chi-square analyses. For frequency data, pairwise comparisons among 
values where the overall Chi-square test reached a significance level of p < .05 were 
corrected for multiple family-wise comparisons using the Holm correction and a 
significance parameter of p < .05.  For interval variables, mean, standard deviation, 
and 95% confidence intervals were calculated. Overall significance was tested using 
one-way analyses of variance (ANOVA), and pairwise comparisons among values 
where the overall test reached a significance level of p < .05 were corrected for 
multiple family-wise comparisons using the Bonferroni correction and a significance 
parameter of p < .05.  
The management and modeling of statistical data for ROC curves was 
performed using STATA software Version 12. The calculation of the Youden index 
and the analyses of differences between groups for proportions were performed using 
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R statistical software Version 3.1.3. Other analyses were performed using SPSS 
software Version 19 and STATA. 
Results 
A total of 1,697 patients were approached to participate in the study because 
their PCPs suspected psychological distress. Of these, 41 patients declined to 
participate in the study because they did not have time (32%), were too ill (17%), 
preferred not to (20%), or for other reasons (31%). There were no difference by 
gender or age group between those who agreed and those who declined to participate 
in the study. Of the 1,656 patients who agreed to participate in the study, 153 patients 
did not complete the interview (e.g., because they did not attend a separate interview 
appointment). Data recording problems required the exclusion of 15 participants from 
the analyses, so the final sample consisted of 1,488 patients with complete data. There 
were no significant differences by gender, age, scores on the anxiety and depression 
scales, or on PCP-rated disability, distress, or disorder severity between the 153 non-
completers and the 1,488 patients included in the final sample.  
 The overall demographic characteristics of the sample by country for gender 
and age, as well as scores on the depression and anxiety screening scales (referred to 
as Dep5 and Anx5) are shown in Table 1. There were significant differences among 
countries on all variables shown in Table 1. A higher proportion of the Chinese 
sample was male (29.2%) than for other countries. On average, participants from 
Pakistan were youngest and participants from China were oldest. Mexican and 
Pakistani participants had the highest average scores on the Dep5, and Chinese 
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participants the lowest, while participants from Brazil and Mexico had the highest 
average scores on the Anx5, and again participants from China had the lowest.  
Table 2 shows the diagnostic results of the CIS-R by country and overall. Of 
the 1,488 participants in the study, 310 (20.8%) had no mood or anxiety disorder 
diagnosis, and 40 (2.7%) had only subclinical mixed depression and anxiety on the 
CIS-R. The remaining 1,138 participants (76.5%) were judged by the CIS-R to have 
one of the three main diagnoses of current anxiety, depression (non-anxious), or 
anxious depression. In all countries, anxious depression was the most common 
disorder, accounting for 725 of the 1138 participants (63.7%) with an above-threshold 
CIS-R diagnosis (i.e., not counting subclinical mixed depression and anxiety), 
compared with 26.1% with current anxiety (n = 297), and 10.2% (n = 116) with non-
anxious depression. The rates for current anxiety were highest in Brazil and Mexico, 
and lowest in Pakistan. Rates for anxious depression were highest in Mexico and 
Pakistan and lowest in China.  
Table 3 shows the country-specific diagnostic accuracy of the five-item 
depression screening scale (Dep5) in detecting cases of both (non-anxious) depression 
and anxious depression, using the CIS-R as a standard. For a clinician, the most 
important properties of a screening scale are the probability that a person with a high 
score is a case (i.e., PPV) and its tendency to correctly identify non-cases (i.e., NPV). 
Cutoff scores were selected using the Youden index (Youden, 1950), based on the 
optimum trade-off between the percentage of cases correctly identified and 
percentage of non-cases correctly identified (López-Ráton et al., 2014). The country-
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specific cutoff score for case identification was 2 for China and 3 for all other 
countries. 
Table 4 shows the overall diagnostic accuracy of the five-item anxiety scale in 
detecting cases of current anxiety and anxious depression. In China and Pakistan, the 
best threshold for case identification was a score of 2, in Mexico it was 3, and in 
Brazil it was 4.  
Table 5 combines the data from the four participating countries, calculating an 
overall value for the relationship between the two five-item screening scales and 
diagnoses of depressive and anxiety disorders according to the CIS-R. Across 
countries, the best cutoff for case identification for both scales across countries was a 
score of 3. 
As noted, the PPVs and NPVs shown in Tables 3 through 5 have been 
calculated using Altman and Bland (1994) formula for general use, which tends to 
yield higher values. For example, for the depression screening scale, the corrected 
PPV for a cutoff of 3 as shown in Table 5 is 0.88 in contrast to an uncorrected value 
of 0.70. The corresponding figures for the anxiety screening scale are 0.89 (shown in 
Table 5) and 0.78.  
Table 6 shows the relationship between diagnostic groupings obtained based 
on the two five-item screening scales and specific diagnoses on the CIS-R. Using a 
cutoff of 3 on both scales (see Table 5), the screening scales correctly classified as 
cases or non-cases 84.0% (CI95 = 82.1% - 85.9%; n =1250) of the 1488 participants, 
including 1020 high scorers with an above threshold diagnosis, and 230 low scorers 
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without one. The screening scales correctly identified 89.6% (CI95 = 87.9% - 
91.4%; n = 1020) of the positive cases and 65.7% (CI95 = 60.7% - 70.7%; n = 230) of 
the non-cases. However, 11.4% (CI95 = 8.8% - 14.8%; n = 40) of the non-cases 
included in this figure were identified as having subclinical mixed depression and 
anxiety by the CIS-R, and if these cases are excluded correct negative case 
identification was 71.0% (CI95 = 65.9 - 76.0%; n = 220). When individuals with 
elevated scores on the screening scales were assigned no diagnosis on the CIS-R, it 
was generally because duration or functional impairment requirements had not been 
met for an above-threshold clinical diagnosis.  
In spite of the very high correlation between depressive and anxious 
symptoms observed in previous studies (Goldberg et al., 2012), the use of both 
screening scales increased the accuracy of case identification. Using only the Dep5, 
the number of CIS-R cases detected dropped to 798 (70.1%; CI95 = 67.5% - 72.8%) of 
the 1138 participants with above-threshold diagnoses on the CIS-R, in contrast to 
1020 cases (89.6%; CI95 = 87.9% - 91.4%) detected using the Dep5 and Anx 5 
together. (See Table 6.) 
The screening scales were not as accurate in assigning specific mood and 
anxiety disorder diagnoses. In only 62.9% of cases with scores of 3 or more on one or 
both screening scales (CI95 = 60.0% - 65.9%; n = 642) was there an exact match 
between the results of the screening scales and the CIS-R diagnosis.  
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Discussion 
Participants in the current study were patients seen in primary care visits in 
centers in four middle-income countries in different parts of the world with different 
languages and broad cultural variation whose PCPs suspected that they might be 
psychologically distressed. The two brief screening scales proposed here were able to 
identify 89.6% (CI95 = 87.9% - 91.4%) of individuals in this sample who had current 
anxiety, depression or anxious depression on a structured diagnostic interview. This is 
a substantial improvement in case identification as compared with available evidence 
related to current primary care practice (Mitchell et al., 2009). This was accomplished 
using a very low-burden screening that could be feasibly implemented in the context 
of a wide range of global primary care settings.  
These screening scales do not require the memorization of complex diagnostic 
algorithms that are used by mental health specialists, which may be difficult for PCPs 
to remember and apply (Krupinski and Tiller 2001; Rapp and Davis 1989). The 
screening scales also provide a useful alternative for global primary care settings to 
paper and pencil screening instruments, which may not be available or may not be 
practical for reasons of language or literacy. The screening scales therefore offer a 
substantially more practical alternative for implementation in low-resource settings. 
Given time and resource pressures, they may also be of considerable value in high-
income countries. 
Among the patients suspected by their PCPs of being psychologically 
distressed who participated in this study, when the long duration requirement for a 
Screening for anxiety, depression, and anxious depression in primary care 
 
 
 
19 
diagnosis of anxiety was removed, anxious depression was by far the most 
common of the group of mood and anxiety disorders. The proposed classification 
draws attention to the distinction between individuals with depression who do and 
who do not have concurrent anxiety. This study affirms the relevance of this approach 
in global primary care settings, as did the results of our earlier focus group study 
(Lam et al., 2013). These two presentations of depressive illness have important 
implications for management and course of illness  (Goldberg, 2014; Goldberg et al., 
2014; VanValkenberg, Akiskal, Puzantian, & Rosenthal, 1984),
 
but the distinction is 
seldom made in clinical practice.  
 The performance of the screening scales in identifying 89.6% (CI95 = 87.9% - 
91.4%) of individuals with an above-threshold depressive or anxiety disorder is in 
contrast to their ability to provide a precise diagnostic assessment among those who 
had high scores (62.9%; CI95 = 60.0% - 65.9%). However, we know that common 
mental disorders merge into one another, without sharp borders between them. 
Research in primary care settings has demonstrated that there is a large common 
component that underlies the allegedly different syndromes of common mental 
disorders (Löwe, Spitzer, Williams, Mussell, Schellberg, & Kroenke, 2008; Simms, 
Prisciandaro, Krueger, & Goldberg, 2012). Thus, anxiety and depression are by no 
means distinct, and the presence of both types of symptoms has significant 
implications for primary care management. The imperfect relationship between the 
exact diagnostic assessment by the two five-item scales and the CIS-R diagnoses 
using full information probably should be understood in terms of the common 
variance between allegedly different mental disorders, and continuity in the two 
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underlying variables at the cases/non-case threshold (Simms et al. 2012). At the 
same time, the most accurate identification of above-threshold CIS-R cases was 
obtained using both the depression and anxiety screening scales together (see Table 
6). 
It is clear from the wide range in proportions of individuals with no depressive 
or anxiety disorder diagnosis across the four countries (Table 2) that there may be 
population differences among countries or among clinical settings, or among the 
thresholds for what might constitute a psychological disorder that should be applied 
by PCPs in a given setting. This relates to a potential difficulty in applying a single 
screening threshold across the world. We have calculated values that combine data for 
all four countries (Table 5), but it may be preferable to use country-specific values 
(Tables 3 and 4) in implementing the scales in any particular context.  
The questions used in the present study were derived from an analysis of data 
from general medical and primary care settings in 14 different countries (Goldberg et 
al., 2012), but it may still be necessary to take account of local variations. It has 
previously been demonstrated that cutoff points for a screening questionnaire can 
vary according to demographic characteristics of the population under study 
(Goldberg, Oldehinkel, & Ormel, 1998; Mari & Williams, 1986). For example, the 
lower cutoff scores for China on both scales (Tables 3 and 4) may reflect 
demographic differences, culturally based reluctance to report psychological 
symptoms, the fact that the Chinese sample was older, or the higher proportion of 
males in the Chinese sample (Mari & Williams, 1986).  
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The greater variability in cutoff scores for the anxiety screening scale 
(Table 4) may suggest that these items could be relatively more susceptible to such 
influences. Indeed, recent studies have found that screening tools such as the 7-item 
Generalized Anxiety Disorder scale (GAD-7) can be culturally dependent and may 
require cultural adaptation in different contexts (Barthel, Barkman, Ehrhardt et al., 
2014; Parkerson, Thibodeau, Brandt et al., 2015; Sousa, Viveiros, Chai et al., 2015). 
These issues will require further research. 
Limitations 
An important limitation of the study is that it was not designed as a prevalence 
study, and therefore does not contain information on patients whose PCPs do not 
consider them to exhibit psychological distress. Thus, the preceding discussion of the 
proportion of cases correctly identified by the screening scales in this sample is by no 
means the same as the sensitivity of the screening questions among all primary care 
patients, and in this sense is likely to be somewhat optimistic. In contrast, the 
proportion of non-cases correctly identified in this sample is likely to be pessimistic, 
as many non-cases are easy to identify and would not have been approached to 
participate in this study. Our methodology was designed to be as non-intrusive as 
possible for administration in busy clinical settings in the four participating middle-
income countries. Clearly, the centers participating in this study may not constitute a 
representative sample of their countries, and these countries do not constitute a 
representative sample of the whole world, but they do represent a substantial 
proportion of the world‘s population and diverse languages, global regions, and 
primary care population characteristics. We hope that these results will encourage 
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other countries to apply and assess the proposed ICD-11 PHC classification of 
anxiety and depression and the related proposed screening tools and thereby 
contribute further to the evidence base in this area.  
Conclusions 
Mood and anxiety disorders are responsible for high proportions of global 
disease burden and disability (Whiteford et al., 2013) and are vastly undertreated 
(WHO World Mental Health Survey Consortium, 2004). Most people who suffer 
from these conditions will never see a mental health specialist, particularly in low- 
and middle-income countries (Kohn, Saxena, Levav, & Saraceno, 2004). For them, 
primary care settings currently represent the best hope for appropriate identification 
and treatment (World Health Organization, 2013; 2016).  
The full decision rules that underlie the specialist classifications of mental 
disorders cannot be applied in primary care settings; there is not enough time and 
PCPs have other important priorities in detecting other health conditions. Even in 
high-income countries, there are considerable pressures on time and resources in 
primary care settings, and limited options for specialist referral for common 
conditions. The revised ICD-11 PHC classification presents a more realistic set of 
descriptions of psychological disorders as they present in primary care. The screening 
scales tested in the current study have the potential to provide major improvements in 
case detection through a procedure that can be feasibly incorporated into global 
primary care practice.  
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While the screening scales cannot make definitive diagnoses, they can 
direct attention to the relative importance of anxious and depressive symptoms in 
determining the patient‘s present state. The dimensions that underlie the two 
screening scales (i.e., depressive symptoms and anxious symptoms) are clinically 
useful in that they are associated with specific treatment approaches that can be 
appropriately implemented in primary care settings (Goldberg, Bridges, Duncan-
Jones, & Grayson, 1987). This is not intended to imply that above-threshold cases 
need pharmacological treatment. Primary care management guidelines developed by 
WHO (WHO, 2016) include a variety of evidence-based behavioral activation and 
psychosocial intervention strategies as well as medications that can improve the lives 
of individuals with mood and anxiety disorders as a part of a comprehensive set of 
strategies to reduce the global burden of mental disorders (WHO, 2013). 
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Table 1. Characteristics of 1,488 participants completing the study, by country and 
overall 
 Brazil China Mexico Pakistan Total 
Female  
(n, %) 
291      
87.7%
a
 
213    
70.8%
b
 
324       
79.4%
c
 
344       
77.0%
c
 
1,172      
78.8% 
Male 
(n, %) 
41      
12.3%
a
 
 88      
29.2%
b
 
 84       
20.6%
c
 
103       
23.0%
b,c
 
316      
22.2% 
Age 
(M, SD) 
48.3
a
 55.5
b 
43.3
c
 38.3
d
 45.4 
SD = 14.5 SD = 15.4 SD = 14.7 SD = 13.3 SD = 15.6 
Average score on 
Dep5  
(M, SD, 95% CI) 
2.5
a
 1.6
b
 3.5
c
 3.5
c
 2.9 
SD = 1.6 
(2.3 - 2.7) 
SD = 1.5 
(1.4 - 1.7) 
SD = 1.6 
(3.3 - 3.6) 
SD = 1.3 
(3.4 - 3.6) 
SD = 1.7 
(2.8 - 3.0) 
Average score on 
Anx5 
(M, SD, 95% CI) 
3.8
a
 2.2
b
 3.5
a
 2.9
c
 3.1 
SD = 1.3 
(3.7 - 4.0) 
SD = 1.4 
(2.0 - 2.4) 
SD = 1.4 
(3.4 - 3.7) 
SD = 1.5 
(2.7 - 3.0) 
SD = 1.5 
(3.1 - 3.2) 
 
Note: M = mean; SD = standard deviation; CI = confidence interval. Significant 
differences (p < 0.001) were found by country for all variables shown. Different 
superscripts for means or percentages across rows indicate significant differences 
between countries designated by different letters, adjusted for multiple comparisons.  
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Table 2. Number and percentages of patients in each diagnostic category based on the 
computerized CIS-R, by country and overall 
 
 
Brazil China Mexico Pakistan Total 
No diagnosis 
(n, %, 95% CI) 
68 135 45 62 310 
  20.5%
 a
 
(16.1- 24.8) 
44.9%
 b
  
(39.2 - 50.5) 
11.0%
c
 
(8.0- 14.1) 
13.9%
 a,c
  
(10.7- 17.1) 
20.8%  
(18.8 - 22.9) 
Subclinical 
Mixed Dep & 
Anxiety 
(n, %, 95% CI) 
6 14 11 9 40 
1.8%  
(0.4 - 3.2) 
4.7% 
(2.3 - 7.0) 
2.7%  
(1.1 - 4.3) 
2.0%  
(1.0 - 3.3) 
2.7% 
(1.9 - 3.5) 
Current 
Anxiety 
(n, %, 95% CI) 
88 57 94 58 297 
26.5%
a
  
(21.7 - 33.2) 
18.9%  
(14.5 - 23.4) 
23.0%
a
 
(18.9 - 27.1) 
13.0%
b
 
(9.9 - 16.1) 
20.0%  
(17.9 - 22.0) 
Depression 
(n, %, 95% CI) 
17 23 29 47 116 
5.1% 
(2.7 - 7.5) 
7.6% 
(4.6 - 10.6) 
7.1% 
(4.6 - 9.6) 
10.5% 
(7.7 - 13.4) 
7.8%  
(6.4 - 9.2) 
Anxious 
depression 
(n, %, 95% CI) 
153 72 229 271 725 
46.1%
a
 
(40.7 - 51.5) 
23.9%
b
 
(19.1 - 28.6) 
56.1%
c
 
(51.3 - 60.9) 
60.6%
c
 
(56.1 - 65.2) 
48.7% 
(46.2 - 51.3) 
Total 
332 
100% 
301 
100% 
408 
100% 
447 
100% 
1,488 
100% 
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Note: CI = confidence interval. Significant differences (p < 0.001) by country were 
found for No diagnosis, Current Anxiety, and Anxious Depression. Different 
superscripts for percentages across rows for these variables indicate significant 
differences between countries designated by different letters, adjusted for multiple 
comparisons.  
 
Table 3. Country-specific diagnostic accuracy of five-item depression scale for 
identifying persons with a clinical diagnosis of depression (without anxiety) or 
anxious depression on the CIS-R 
 
 
 
Country 
 
N 
 
AUC 
% cases 
correct 
% noncases 
correct PPV NPV 
Youden 
index 
Dep5
score 
Probability 
of caseness 
Brazil 0 50 0.04 0.83 1.00 0.00 0.06   
 
 
1 50 0.14  0.99 0.30 0.25 0.99 0.28 
 
2 68 0.50  0.95 0.56 0.65 0.93 0.51 
 
3 60 0.70  0.75 0.77 0.88 0.57 0.52 
 
4 71 0.77  0.50 0.88 0.94 0.33 0.38 
 
5 33 0.91   0.18 0.98 0.99 0.08 0.16 
China 0 96 0.03 0.88 1.00 0.00 0.06   
 
 
1 69 0.13 
 
0.97 0.45 0.29 0.98 0.42 
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2 47 0.36 
 
0.87 0.74 0.74 0.87 0.61 
 
3 38 0.58 
 
0.69 0.89 0.93 0.56 0.58 
 
4 30 0.77 
 
0.46 0.97 0.98 0.33 0.43 
 
5 21 1.00 
 
0.22 1.00 1.00 0.09 0.22 
Mexico 0 42 0.14 0.79 1.00 0.00 0.06   
 
 
1 53 0.34 
 
0.98 0.24 0.23 0.98 0.22 
 
2 70 0.56 
 
0.91 0.47 0.59 0.86 0.38 
 
3 70 0.71 
 
0.76 0.68 0.84 0.55 0.44 
 
4 83 0.75 
 
0.56 0.81 0.92 0.34 0.37 
 
5 90 0.92 
 
0.32 0.95 0.99 0.09 0.27 
Pakistan 0 35 0.09 0.82 1.00 0.00 0.06   
 
 
1 17 0.12  0.99 0.25 0.24 0.99 0.24 
 
2 27 0.26  0.98 0.36 0.57 0.96 0.34 
 
3 116 0.72   0.96 0.52 0.82 0.86 0.48 
 
4 117 0.82  0.70 0.77 0.92 0.41 0.47 
 5 135 0.93   0.40 0.93 0.99 0.10 0.33 
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Note: In Tables 3 – 5, ‗% cases correct‘ = % CIS-R cases correctly identified 
using the five-item screening scale at each possible cutoff; ‗% noncases 
correct‘ = % non-cases correctly identified; AUC = Area under curve; PPV = 
Positive Predictive Value; NPV = Negative Predictive Value. PPV and NPV were 
calculated using the formula provided by Altman and Bland (1994). Optimized cutoff 
scores, shaded in gray, were selected using the Youden index (Youden, 1950). 
 
Table 4. Country-specific diagnostic accuracy of five-item anxiety scale for 
identifying persons with a clinical diagnosis of anxiety or anxious depression on the 
CIS-R 
 
 
 
Country 
Anx
5 
N 
Probabilit
y 
AU
C 
% cases 
correct 
% noncases 
correct 
PP
V 
NP
V 
Youde
n 
index score of caseness 
Brazil 0 18 0.33 0.74 1.00 0.00 0.27  
 
 
1 23 0.48  0.98 0.13 0.45 0.88 0.11 
 
2 28 0.43  0.93 0.26 0.72 0.65 0.19 
 
3 56 0.64  0.88 0.44 0.84 0.51 0.32 
 
4 77 0.79  0.73 0.66 0.91 0.34 0.39 
 
5 
13
0 
0.88   0.48 0.84 
0.95 0.19 0.31 
China 
0 
10
4 
0.14 0.81 1.00 0.00 
0.27 
 
 
 
1 42 0.19 
 
0.88 0.52 0.57 0.86 0.4 
 
2 43 0.47 
 
0.82 0.72 0.85 0.67 0.54 
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3 48 0.77 
 
0.67 0.85 0.94 0.42 0.52 
 
4 41 0.73 
 
0.38 0.91 0.95 0.24 0.29 
 
5 23 0.83 
 
0.15 0.98 0.98 0.14 0.13 
Mexico 0 26 0.31 0.78 1.00 0.00 0.27  
 
 
1 36 0.50 
 
0.98 0.21 0.47 0.92 0.19 
 
2 49 0.59 
 
0.92 0.42 0.76 0.72 0.34 
 
3 62 0.85 
 
0.83 0.66 0.89 0.53 0.49 
 
4 87 0.91 
 
0.67 0.76 0.93 0.33 0.43 
 
5 
14
8 
0.92 
 
0.42 0.86 
0.95 0.18 0.28 
Pakista
n 
0 93 0.40 0.69 1.00 0.00 
0.27 
 
 
 
1 28 0.61 
 
0.89 0.47 0.55 0.85 0.36 
 
2 79 0.91 
 
0.84 0.57 0.80 0.63 0.41 
 
3 53 0.83 
 
0.62 0.63 0.85 0.32 0.25 
 
4 58 0.81 
 
0.48 0.70 0.88 0.22 0.18 
  
5 
13
6 
0.82 
 
0.34 0.80 
0.92 0.15 0.14 
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Table 5. Overall diagnostic accuracy across countries of the five-item depression 
scale for identifying persons with a clinical diagnosis of current depression or anxious 
depression on the CIS-R; overall accuracy of the five-item anxiety scale for 
identifying persons with a clinical diagnosis of current anxiety or anxious depression 
on the CIS-R 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Overall score 
across countries N 
Probability 
of caseness AUC 
% cases 
correct 
% noncases 
correct PPV NPV 
Youden 
index 
Dep5 score 
        0 223 0.06 0.85 1.00 0.00 0.06  
 1 189 0.19  0.98 0.32 0.25 0.99 0.31 
2 212 0.46  0.94 0.56 0.64 0.92 0.50 
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3 284 0.70   0.83 0.74 0.88 0.65 0.56 
4 301 0.78  0.59 0.87 0.94 0.37 0.46 
5 279 0.93   0.31 0.97 0.99 0.09 0.28 
Anx5 score 
        0 241 0.27 0.77 1.00 0.00 0.27  
 1 129 0.42  0.94 0.38 0.52 0.89 0.31 
2 199 0.67  0.88 0.54 0.79 0.69 0.42 
3 219 0.78  0.75 0.68 0.89 0.44 0.43 
4 263 0.83  0.59 0.78 0.93 0.29 0.37 
5 437 0.87   0.37 0.88 0.96 0.17 0.26 
 
 
Table 6. Relationships among diagnostic groupings based on the two five-item 
screening scales and specific diagnoses on the CIS-R 
 
 
Screening 
Questions 
No dx 
Mixed 
Anx/Dep 
(subclinical) 
Current 
anxiety 
Non-
anxious 
depression 
Anxious 
depression  Total 
Subthreshold 220, 63.2% 10, 2.9% 74, 21.3% 17, 4.9% 27, 7.8% 348 
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n, % 
[95% CI] 
[58.1 - 68.3] [2.3 - 5.4] [17.0 - 25.6] [2.6 - 7.2] [4.9 - 10.6] 100% 
High Anx only 
n, % 
[95% CI] 
44, 15.9% 
[11.6 - 20.3] 
10, 3.6% 
[1.4 - 5.8] 
119, 43.1% 
[37.3 - 49.0] 
14, 5.1% 
[2.5 - 7.7] 
89, 32.3% 
[26.7 - 37.8] 
276 
100% 
High Dep only 
n, % 
[95% CI] 
21, 9.5% 
[5.6 - 13.4] 
10, 4.5% 
[1.8 - 7.3] 
28, 12.7% 
[8.3 - 17.1] 
38, 17.2% 
[12.2 - 22.2] 
124, 56.1% 
[49.5 - 62.7] 
221 
100% 
High Anx & 
High Dep 
n, % 
[95% CI] 
25, 3.9% 
[2.4 - 5.4] 
10, 1.6% 
[0.6 - 2.5] 
76, 11.8% 
[9.3 - 14.3] 
47, 7.3% 
[5.3 - 9.3] 
485, 75.3% 
[72.1 - 78.8] 
643 
100% 
Total 
n, % 
[95% CI] 
310, 20.8% 
[18.8 - 22.9] 
40, 2.7% 
[1.9 - 3.5] 
297, 20.0% 
[17.9 - 22.0] 
116, 7.8% 
  [6.4 - 9.2] 
725, 48.7% 
[46.2 - 51.3] 
1,488 
100% 
 
 
Note: For the above groupings based on the two five-item screening scales: High 
Anxiety only indicates a score of 3 or above on the Anx5 and a score of 2 or below 
on the Dep5; High Depression only indicates a score of 3 or above on the Dep5 and a 
score of 2 or below on the Anx5; and High Anxiety and High Depression indicates a 
score of 3 or above on the Dep5 and a score of 3 or above on Anx5.  
 
 
Highlights 
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 Study participants presented with psychological distress to primary care 
physicians in 4 countries 
 Two five-item screening scales for anxiety and depression were used 
 Participants also received a structured psychiatric diagnostic interview  
 The optimal cutoff score for both scales was 3, across four participating 
countries 
 Screening scale scores predicted 89.6% of above-threshold mood or anxiety 
disorders 
 This represents a major improvement in detection compared with current 
practice 
 
